Methotrexate therapy for squamous cell carcinomas of the head and neck. Intermittent intravenous dose program

JAMA. 1968 May 13;204(7):561-4.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Blood Cell Count
  • Body Weight / drug effects
  • Carcinoma, Squamous Cell / drug therapy*
  • Ear Neoplasms / drug therapy
  • Epiglottis
  • Facial Neoplasms / drug therapy
  • Humans
  • Injections, Intravenous
  • Laryngeal Neoplasms / drug therapy
  • Methotrexate / administration & dosage*
  • Methotrexate / adverse effects
  • Middle Aged
  • Mouth Mucosa / drug effects
  • Mouth Neoplasms / drug therapy*
  • Nasopharyngeal Neoplasms / drug therapy*
  • Palatal Neoplasms / drug therapy
  • Pharyngeal Neoplasms / drug therapy
  • Tongue Neoplasms / drug therapy
  • Tonsillar Neoplasms / drug therapy

Substances

  • Methotrexate